Wall Street consensus, price target range, and equity research thesis
Wall Street currently rates CRM buy with a 12-month price target of $272 (+16.6% upside). The sections below cover the bull case, key risks, and latest earnings context for Salesforce, Inc..
Recent Analyst Actions
11 of 18 analysts cut targets. Recent price target changes and ratings for CRM.
| Firm | Action | Rating | Price Target |
|---|---|---|---|
| Citigroup | Cut | Neutral | $188$187 |
| Canaccord Genuity | Cut | Buy | $250$225 |
| Bernstein | Cut | Underperform | $194$173 |
| TD Cowen | Cut | Buy | $250$240 |
| Macquarie | Cut | Neutral | $200$190 |
| Barclays | Cut | Overweight | $252$236 |
| Wells Fargo | Cut | Equal-Weight | $210$200 |
| Citizens | Maintained | Market Outperform | $315$315 |
Analyst ratings update weekly. Get CRM's next verdict in your inbox.
Free. No account needed. Unsubscribe any time.
Analyst Research Summary
A structured look at the bull case, the risks, and the most recent earnings execution for CRM.
CRM beat estimates last quarter. Below are the key reasons analysts remain constructive and the risks that could change that view.
What keeps the long thesis intact
Wall Street rates CRM buy, giving the bull case institutional backing from 98 analysts.
What can break the setup quickly
Watch whether new negative commentary on CRM points to these structural risks or is simply reacting to short-term price moves.
Last Quarter
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Stock snapshot, live price chart, key ratios, and company profile.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CRM stock.
CRM has modest upside — analysts rate it "Buy" with a $272 target, implying +16.6% from today's $233.28. This is informational only — verify the data and consider your own risk tolerance before deciding.
Timing depends on your horizon, but the data signals are: consensus rating "Buy" with +16.6% upside to the $272 target. In the past 30 days, 11 of 18 covering analysts cut their price targets — a bearish signal.
CRM's consensus 12-month price target is $272, set by 98 Wall Street analysts. The bull case high is $325 and the bear case low is $215. From the current price of $233.28, this implies +16.6% upside.
CRM appears undervalued — the $272 consensus target is +16.6% above today's $233.28. It trades at a forward P/E of 14.0x. Targets range from $215 (bear) to $325 (bull), reflecting different assumptions about growth and margins.
CRM reports next quarter. Earnings-week moves are volatile — historically, analyst targets revise upward after a beat and downward after a miss. The current consensus is "Buy" with a $272 target. Consider position sizing rather than going all-in pre-print.
Of 98 analysts covering Salesforce, Inc. (CRM): 2 Strong Buy, 73 Buy, 21 Hold, 2 Sell, 0 Strong Sell — a "Buy" consensus. The 12-month price target is $272 (range $215–$325). Bullish analysts outnumber bearish by more than 2-to-1.
2 of the 98 analysts covering CRM rate it Sell or Strong Sell. Common concerns include valuation stretch, slowing growth, and sector-specific headwinds — see the Bull vs. Risk cards above for the specific theses on Salesforce, Inc..
Financial Data & Software Notice: VCP Scanner is an educational financial research database and stock screening software platform. VCP Scanner does not generate, recommend, or package trade decisions, buy/sell signals, or personalized investment advice. Consensus ratings and price targets reflect aggregated third-party Wall Street analyst research from public SEC filings. See our Terms of Service and Privacy Policy.